More recently, using simplified kinetic analysis with determination of SUV at different time points, Ginet et al. showed that IDH-wildtype gliomas, which are associated with a poorer outcome (28), have a shorter TTP than IDH-mutant gliomas (13). The gene discussed is IDH1; the disease is central nervous system cancer.